1. Home
  2. RGNX vs TYG Comparison

RGNX vs TYG Comparison

Compare RGNX & TYG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGNX
  • TYG
  • Stock Information
  • Founded
  • RGNX 2008
  • TYG 2003
  • Country
  • RGNX United States
  • TYG United States
  • Employees
  • RGNX N/A
  • TYG N/A
  • Industry
  • RGNX Biotechnology: Biological Products (No Diagnostic Substances)
  • TYG Investment Managers
  • Sector
  • RGNX Health Care
  • TYG Finance
  • Exchange
  • RGNX Nasdaq
  • TYG Nasdaq
  • Market Cap
  • RGNX 387.0M
  • TYG 441.8M
  • IPO Year
  • RGNX 2015
  • TYG N/A
  • Fundamental
  • Price
  • RGNX $8.54
  • TYG $42.19
  • Analyst Decision
  • RGNX Strong Buy
  • TYG
  • Analyst Count
  • RGNX 8
  • TYG 0
  • Target Price
  • RGNX $31.75
  • TYG N/A
  • AVG Volume (30 Days)
  • RGNX 1.1M
  • TYG 53.1K
  • Earning Date
  • RGNX 07-31-2025
  • TYG 01-01-0001
  • Dividend Yield
  • RGNX N/A
  • TYG 10.37%
  • EPS Growth
  • RGNX N/A
  • TYG N/A
  • EPS
  • RGNX N/A
  • TYG 19.59
  • Revenue
  • RGNX $156,718,000.00
  • TYG $13,675,460.00
  • Revenue This Year
  • RGNX $327.08
  • TYG N/A
  • Revenue Next Year
  • RGNX N/A
  • TYG N/A
  • P/E Ratio
  • RGNX N/A
  • TYG $2.16
  • Revenue Growth
  • RGNX 80.70
  • TYG N/A
  • 52 Week Low
  • RGNX $5.04
  • TYG $33.09
  • 52 Week High
  • RGNX $15.36
  • TYG $48.76
  • Technical
  • Relative Strength Index (RSI)
  • RGNX 46.38
  • TYG 56.52
  • Support Level
  • RGNX $7.82
  • TYG $41.77
  • Resistance Level
  • RGNX $10.64
  • TYG $42.97
  • Average True Range (ATR)
  • RGNX 0.82
  • TYG 0.69
  • MACD
  • RGNX -0.19
  • TYG -0.01
  • Stochastic Oscillator
  • RGNX 25.57
  • TYG 53.97

About RGNX REGENXBIO Inc.

Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.

About TYG Tortoise Energy Infrastructure Corporation

Tortoise Energy Infrastructure Corp seeks to provide a high level of current income to stockholders. It invests in fixed-income and dividend-paying equity securities of power and energy infrastructure companies that provide stable and defensive characteristics throughout economic cycles.

Share on Social Networks: